TARDBP and amyotrophic lateral sclerosis: The present study aimed to uncover circulating biomarkers by analyzing plasma miRNA expression levels in a large ALS family (7 symptomatic patients, 7 asymptomatic mutation carriers, and 13 healthy controls) characterized by a rare mutation in the TARDBP gene.